307 related articles for article (PubMed ID: 29572166)
1. The Effects of N-terminal Mutations on β-amyloid Peptide Aggregation and Toxicity.
Foroutanpay BV; Kumar J; Kang SG; Danaei N; Westaway D; Sim VL; Kar S
Neuroscience; 2018 May; 379():177-188. PubMed ID: 29572166
[TBL] [Abstract][Full Text] [Related]
2. Aβ-40 Y10F increases βfibrils formation but attenuates the neurotoxicity of amyloid-β peptide.
Dai X; Chang P; Liu W; Xu K; Sun Y; Zhu S; Jiang Z
Int J Mol Sci; 2012; 13(5):5324-5337. PubMed ID: 22754299
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of a highly soluble Aβ
LeVatte MA; Lipfert M; Ladner-Keay C; Wishart DS
Protein Expr Purif; 2019 Dec; 164():105480. PubMed ID: 31425755
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Dictates Divergent Fates for the Central Salt Bridges in Amyloid-β
Chandra B; Mithu VS; Bhowmik D; Das AK; Sahoo B; Maiti S; Madhu PK
Biophys J; 2017 Apr; 112(8):1597-1608. PubMed ID: 28445751
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of β-Amyloid Toxicity In Vitro and In Vivo by Accelerated Aggregation.
Yang A; Wang C; Song B; Zhang W; Guo Y; Yang R; Nie G; Yang Y; Wang C
Neurosci Bull; 2017 Aug; 33(4):405-412. PubMed ID: 28555357
[TBL] [Abstract][Full Text] [Related]
6. Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity.
Diomede L; Di Fede G; Romeo M; Bagnati R; Ghidoni R; Fiordaliso F; Salio M; Rossi A; Catania M; Paterlini A; Benussi L; Bastone A; Stravalaci M; Gobbi M; Tagliavini F; Salmona M
Neurobiol Dis; 2014 Feb; 62():521-32. PubMed ID: 24184799
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for self-propagation of different amyloid-β fibril conformations.
Spirig T; Ovchinnikova O; Vagt T; Glockshuber R
Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967
[TBL] [Abstract][Full Text] [Related]
8. The new β amyloid-derived peptide Aβ1-6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity.
Diomede L; Romeo M; Cagnotto A; Rossi A; Beeg M; Stravalaci M; Tagliavini F; Di Fede G; Gobbi M; Salmona M
Neurobiol Dis; 2016 Apr; 88():75-84. PubMed ID: 26792398
[TBL] [Abstract][Full Text] [Related]
9. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
[TBL] [Abstract][Full Text] [Related]
10. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
[TBL] [Abstract][Full Text] [Related]
11. Amyloidogenicity and Cytotoxicity of a Recombinant C-Terminal His
Jia L; Wang W; Sang J; Wei W; Zhao W; Lu F; Liu F
ACS Chem Neurosci; 2019 Mar; 10(3):1251-1262. PubMed ID: 30537813
[TBL] [Abstract][Full Text] [Related]
12. An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability.
Oren O; Banerjee V; Taube R; Papo N
Biochem J; 2018 Oct; 475(19):3087-3103. PubMed ID: 30213841
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic Aβ A2V versus protective Aβ A2T mutation: Early stage aggregation and membrane interaction.
Colombo L; Gamba A; Cantù L; Salmona M; Tagliavini F; Rondelli V; Del Favero E; Brocca P
Biophys Chem; 2017 Oct; 229():11-18. PubMed ID: 28502484
[TBL] [Abstract][Full Text] [Related]
14. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA
FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556
[TBL] [Abstract][Full Text] [Related]
15. Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake.
Chafekar SM; Baas F; Scheper W
Biochim Biophys Acta; 2008 Sep; 1782(9):523-31. PubMed ID: 18602001
[TBL] [Abstract][Full Text] [Related]
16. Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer's disease.
Yamakawa MY; Uchino K; Watanabe Y; Adachi T; Nakanishi M; Ichino H; Hongo K; Mizobata T; Kobayashi S; Nakashima K; Kawata Y
Nutr Neurosci; 2016; 19(1):32-42. PubMed ID: 26304685
[TBL] [Abstract][Full Text] [Related]
17. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo JF; Howell KG
J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity.
Lin TW; Chang CF; Chang YJ; Liao YH; Yu HM; Chen YR
PLoS One; 2017; 12(3):e0174561. PubMed ID: 28362827
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylcholine increases the neurotoxicity of Alzheimer's amyloid β1-42 peptide: role of oligomer formation.
Sheikh AM; Michikawa M; Kim SU; Nagai A
Neuroscience; 2015 Apr; 292():159-69. PubMed ID: 25727637
[TBL] [Abstract][Full Text] [Related]
20. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
Arai T; Sasaki D; Araya T; Sato T; Sohma Y; Kanai M
Chembiochem; 2014 Nov; 15(17):2577-83. PubMed ID: 25262917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
